These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34244123)

  • 21. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting Risk for Incident Heart Failure With Omega-3 Fatty Acids: From MESA.
    Block RC; Liu L; Herrington DM; Huang S; Tsai MY; O'Connell TD; Shearer GC
    JACC Heart Fail; 2019 Aug; 7(8):651-661. PubMed ID: 31302044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
    Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Vascular Cell Adhesion Molecule-1 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Patel RB; Colangelo LA; Bielinski SJ; Larson NB; Ding J; Allen NB; Michos ED; Shah SJ; Lloyd-Jones DM
    J Am Heart Assoc; 2020 Nov; 9(22):e019390. PubMed ID: 33161805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lp(a) [Lipoprotein(a)]-Related Risk of Heart Failure Is Evident in Whites but Not in Other Racial/Ethnic Groups.
    Steffen BT; Duprez D; Bertoni AG; Guan W; Tsai MY
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2498-2504. PubMed ID: 30354212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left Ventricular Mass at MRI and Long-term Risk of Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Kawel-Boehm N; Kronmal R; Eng J; Folsom A; Burke G; Carr JJ; Shea S; Lima JAC; Bluemke DA
    Radiology; 2019 Oct; 293(1):107-114. PubMed ID: 31453766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study.
    Lewis AA; Ayers CR; Selvin E; Neeland I; Ballantyne CM; Nambi V; Pandey A; Powell-Wiley TM; Drazner MH; Carnethon MR; Berry JD; Seliger SL; DeFilippi CR; de Lemos JA
    Circulation; 2020 Mar; 141(12):957-967. PubMed ID: 31931608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
    Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
    J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum reactivity to citrullinated protein/peptide antigens and left ventricular structure and function in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Hughes-Austin JM; Katz R; Majka DS; Criqui MH; Robinson WH; Firestein GS; Hundley WG; Ix JH
    PLoS One; 2023; 18(10):e0291967. PubMed ID: 37874814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA.
    Almahmoud MF; Soliman EZ; Bertoni AG; Kestenbaum B; Katz R; Lima JAC; Ouyang P; Miller PE; Michos ED; Herrington DM
    J Am Heart Assoc; 2018 Sep; 7(18):e008334. PubMed ID: 30371180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resting heart rate as predictor for left ventricular dysfunction and heart failure: MESA (Multi-Ethnic Study of Atherosclerosis).
    Opdahl A; Ambale Venkatesh B; Fernandes VRS; Wu CO; Nasir K; Choi EY; Almeida ALC; Rosen B; Carvalho B; Edvardsen T; Bluemke DA; Lima JAC
    J Am Coll Cardiol; 2014 Apr; 63(12):1182-1189. PubMed ID: 24412444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of incident heart failure by serum amino-terminal pro-B-type natriuretic peptide level in a community-based cohort.
    Campbell DJ; Gong FF; Jelinek MV; Castro JM; Coller JM; McGrady M; Boffa U; Shiel L; Wang BH; Liew D; Wolfe R; Stewart S; Owen AJ; Krum H; Reid CM; Prior DL
    Eur J Heart Fail; 2019 Apr; 21(4):449-459. PubMed ID: 30656792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling.
    Voros G; Ector J; Garweg C; Droogne W; Van Cleemput J; Peersman N; Vermeersch P; Janssens S
    Circ Heart Fail; 2018 Dec; 11(12):e004953. PubMed ID: 30562098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
    Brunner-La Rocca HP; Eurlings L; Richards AM; Januzzi JL; Pfisterer ME; Dahlström U; Pinto YM; Karlström P; Erntell H; Berger R; Persson H; O'Connor CM; Moertl D; Gaggin HK; Frampton CM; Nicholls MG; Troughton RW
    Eur J Heart Fail; 2015 Dec; 17(12):1252-61. PubMed ID: 26419999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sedentary Time and Cumulative Risk of Preserved and Reduced Ejection Fraction Heart Failure: From the Multi-Ethnic Study of Atherosclerosis.
    Rariden BS; Boltz AJ; Brawner CA; Pinkstaff SO; Richardson MR; Johnson TM; Churilla JR
    J Card Fail; 2019 Jun; 25(6):418-424. PubMed ID: 30930104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic Guanosine Monophosphate and Risk of Incident Heart Failure and Other Cardiovascular Events: the ARIC Study.
    Zhao D; Guallar E; Vaidya D; Ndumele CE; Ouyang P; Post WS; Lima JA; Ying W; Kass DA; Hoogeveen RC; Shah SJ; Subramanya V; Michos ED
    J Am Heart Assoc; 2020 Jan; 9(2):e013966. PubMed ID: 31928156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Bansal N; Zelnick L; Go A; Anderson A; Christenson R; Deo R; Defilippi C; Lash J; He J; Ky B; Seliger S; Soliman E; Shlipak M; ;
    J Am Heart Assoc; 2019 Nov; 8(21):e012336. PubMed ID: 31645163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study.
    Lam CSP; Gamble GD; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Cameron VA; Poppe K; Lund M; Devlin G; Troughton R; Richards AM; Doughty RN
    Eur Heart J; 2018 May; 39(20):1770-1780. PubMed ID: 29390051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.